Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (FY)Jan 31, 2023 | (FY)Jan 31, 2022 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | 17.33M | 18.24M | 16.93M | 99.82%73.32M | 37.33M | 8,015.35%36.69M | 452.12K |
| Net profit before non-cash adjustment | --17.81M | --16.53M | --15.14M | 102.22%45.15M | --11.14M | 164.17%22.32M | ---34.79M |
| Total adjustment of non-cash items | --9.41M | --9.21M | --9.34M | 52.04%22.87M | --8.05M | -59.45%15.04M | --37.1M |
| -Depreciation and amortization | ---- | ---- | ---- | 40.49%15.92M | --5.04M | -3.33%11.34M | --11.73M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 148.84%2.23M | --1.89M | -96.27%896.3K | --24.01M |
| -Disposal profit | ---- | ---- | ---- | 89.69%-10.33K | ---19.73K | -514.62%-100.16K | ---16.3K |
| -Net exchange gains and losses | ---- | ---- | ---- | --0 | --0 | -64.16%338 | --943 |
| -Other non-cash items | --9.41M | --9.21M | --9.34M | 62.36%4.72M | --1.14M | 111.76%2.91M | --1.37M |
| Changes in working capital | ---9.89M | ---7.5M | ---7.55M | 885.60%5.3M | --18.14M | 63.59%-674.88K | ---1.85M |
| -Change in receivables | ---15.76M | ---8.86M | ---4.4M | 125.49%2.54M | --30.37M | -174.02%-9.96M | ---3.63M |
| -Change in inventory | ---532K | --64K | ---490K | -181.53%-76.37K | --43.6K | 523.14%93.67K | --15.03K |
| -Change in payables | --6.4M | --1.29M | ---2.66M | -69.10%2.84M | ---12.28M | 420.54%9.19M | --1.77M |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | -2.37M | ||||||
| Interest received (cash flow from operating activities) | |||||||
| Tax refund paid | -4.45M | -7.07M | -2.14M | 99.05%-9K | -6.65K | 54.97%-949.62K | -2.11M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | --10.52M | --6.75M | --14.79M | 105.10%73.31M | --37.33M | 2,257.61%35.74M | ---1.66M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | ---8.21M | ---9.17M | ---2.72M | 10.92%-24.21M | ---19.61M | -129,357.24%-27.17M | ---20.99K |
| Net intangibles purchase and sale | ---- | ---- | ---- | 66.67%-4.5K | --0 | ---13.5K | --0 |
| Net investment product transactions | ---- | ---- | ---56.63M | 199.70%2.83M | --0 | -53,266.35%-2.84M | ---5.31K |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | 16.67%-7.01M | --8.12M | -955.57%-8.42M | --983.88K |
| Interest received (cash flow from investment activities) | --1.02M | ---- | ---- | -93.09%8.85K | --5.61K | 142.42%128.12K | --52.85K |
| Net changes in other investments | ---- | ---- | ---- | -17.26%-9.12M | ---- | -140.54%-7.77M | ---3.23M |
| Investing cash flow | ---7.18M | --48.98M | ---59.35M | 18.62%-37.5M | ---20.6M | -1,974.77%-46.08M | ---2.22M |
| Financing cash flow | |||||||
| Net issuance payments of debt | ---3.51M | ---3.29M | ---3.28M | -71.84%8.01M | --130.04K | 234.58%28.46M | --8.5M |
| Net common stock issuance | --0 | --0 | --114.04M | --0 | --0 | --0 | --0 |
| Increase or decrease of lease financing | ---2.91M | ---2.72M | ---2.55M | -74.18%-12.83M | ---3.37M | -107.20%-7.36M | ---3.55M |
| Cash dividends paid | ---5M | ---5M | ---9M | ---21M | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | -70.14%-2.51M | ---573.98K | -52.67%-1.48M | ---967.69K |
| Financing cash flow | ---11.41M | ---11.01M | --99.21M | -244.44%-28.33M | ---24.82M | 392.48%19.61M | --3.98M |
| Net cash flow | |||||||
| Beginning cash position | --146.08M | --101.41M | --47.05M | 104.92%17.46M | --33.85M | 0.85%8.52M | --8.45M |
| Current changes in cash | ---8.08M | --44.72M | --54.65M | -19.38%7.47M | ---8.09M | 8,744.89%9.27M | --104.8K |
| Effect of exchange rate changes | ---452K | ---47K | ---291K | 356.10%849.89K | --26.19K | -904.39%-331.86K | ---33.04K |
| End cash Position | --137.54M | --146.08M | --101.41M | 47.68%25.78M | --25.78M | 104.92%17.46M | --8.52M |
| Free cash flow | --2.31M | ---2.42M | --12.06M | 476.19%48.71M | --17.59M | 567.10%8.45M | ---1.81M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.